Genetic Anticipation Is Associated with Telomere Shortening in Hereditary Breast Cancer

English version České info

There is increasing evidence suggesting that short telomeres and subsequent genomic instability contribute to malignant transformation. Telomere shortening has been described as a mechanism to explain genetic anticipation in dyskeratosis congenita and Li-Fraumeni syndrome. Since genetic anticipation has been observed in familial breast cancer, we aimed to study telomere length in familial breast cancer patients and hypothesized that genetic defects causing this disease would affect telomere maintenance resulting in shortened telomeres. Here, we first investigated age anticipation in mother-daughter pairs with breast cancer in 623 breast cancer families, classified as BRCA1, BRCA2, and BRCAX. Moreover, we analyzed telomere length in DNA from peripheral blood leukocytes by quantitative PCR in a set of 198 hereditary breast cancer patients, and compared them with 267 control samples and 71 sporadic breast cancer patients. Changes in telomere length in mother-daughter pairs from breast cancer families and controls were also evaluated to address differences through generations. We demonstrated that short telomeres characterize hereditary but not sporadic breast cancer. We have defined a group of BRCAX families with short telomeres, suggesting that telomere maintenance genes might be susceptibility genes for breast cancer. Significantly, we described that progressive telomere shortening is associated with earlier onset of breast cancer in successive generations of affected families. Our results provide evidence that telomere shortening is associated with earlier age of cancer onset in successive generations, suggesting that it might be a mechanism of genetic anticipation in hereditary breast cancer.

Vyšlo v časopise: Genetic Anticipation Is Associated with Telomere Shortening in Hereditary Breast Cancer. PLoS Genet 7(7): e32767. doi:10.1371/journal.pgen.1002182
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002182

Souhrn

Zdroje

1. BrookJDMcCurrachMEHarleyHGBucklerAJChurchD 1992 Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 69 385

2. ScholsLBauerPSchmidtTSchulteTRiessO 2004 Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 3 291 304

3. NilbertMTimshelSBernsteinILarsenK 2009 Role for genetic anticipation in Lynch syndrome. J Clin Oncol 27 360 364

4. WestphalenAARussellAMBuserMBerthodCRHutterP 2005 Evidence for genetic anticipation in hereditary non-polyposis colorectal cancer. Hum Genet 116 461 465

5. SegelGBLichtmanMA 2004 Familial (inherited) leukemia, lymphoma, and myeloma: an overview. Blood Cells Mol Dis 32 246 261

6. BrownBWCostelloTJHwangSJStrongLC 2005 Generation or birth cohort effect on cancer risk in Li-Fraumeni syndrome. Hum Genet 118 489 498

7. TaboriUNandaSDrukerHLeesJMalkinD 2007 Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. Cancer Res 67 1415 1418

8. TrkovaMProchazkovaKKrutilkovaVSumerauerDSedlacekZ 2007 Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age. Cancer 110 694 702

9. DaganEGershoni-BaruchR 2001 Hereditary breast/ovarian cancer–pitfalls in genetic counseling. Clin Genet 60 310 313

10. PatersonADKennedyJLPetronisA 1996 Evidence for genetic anticipation in non-Mendelian diseases. Am J Hum Genet 59 264 268

11. PeixotoASalgueiroNSantosCVarzimGRochaP 2006 BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families. Fam Cancer 5 379 387

12. ArmaniosMChenJLChangYPBrodskyRAHawkinsA 2005 Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci U S A 102 15960 15964

13. VulliamyTMarroneASzydloRWalneAMasonPJ 2004 Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 36 447 449

14. WilleitPWilleitJMayrAWegerSOberhollenzerF 2010 Telomere length and risk of incident cancer and cancer mortality. JAMA 304 69 75

15. WuXAmosCIZhuYZhaoHGrossmanBH 2003 Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 95 1211 1218

16. PooleyKASandhuMSTyrerJShahMDriverKE 2010 Telomere length in prospective and retrospective cancer case-control studies. Cancer Res 70 3170 3176

17. ShenJGammonMDTerryMBWangQBradshawP 2009 Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer 124 1637 1643

18. ShenJTerryMBGurvichILiaoYSenieRT 2007 Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 67 5538 5544

19. SvensonUNordfjallKStegmayrBManjerJNilssonP 2008 Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res 68 3618 3623

20. HedenfalkIRingnerMBen-DorAYakhiniZChenY 2003 Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc Natl Acad Sci U S A 100 2532 2537

21. BlascoMA 2005 Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6 611 622

22. BallalRDSahaTFanSHaddadBRRosenEM 2009 BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage. J Biol Chem 284 36083 36098

23. CabuyENewtonCSlijepcevicP 2008 BRCA1 knock-down causes telomere dysfunction in mammary epithelial cells. Cytogenet Genome Res 122 336 342

24. McPhersonJPHandeMPPoonepalliALemmersBZablockiE 2006 A role for Brca1 in chromosome end maintenance. Hum Mol Genet 15 831 838

25. BadieSEscandellJMBouwmanPCarlosARThanasoulaM 2010 BRCA2 acts as a RAD51 loader to facilitate telomere replication and capping. Nat Struct Mol Biol 17 1461 1469

26. CaladoRTYoungNS 2009 Telomere diseases. N Engl J Med 361 2353 2365

27. KingMCMarksJHMandellJB 2003 Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302 643 646

28. PatersonADNaimarkDMHuangJVachonCPetronisA 1999 Genetic anticipation and breast cancer: a prospective follow-up study. Breast Cancer Res Treat 55 21 28

29. HohJHeitjanDFMeretteCOttJ 2001 Ascertainment and anticipation in family studies. Hum Hered 51 23 26

30. VehmanenPFriedmanLSEerolaHSarantausLPyrhonenS 1997 A low proportion of BRCA2 mutations in Finnish breast cancer families. Am J Hum Genet 60 1050 1058

31. De VivoIPrescottJWongJYKraftPHankinsonSE 2009 A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 18 1152 1156

32. ZhengYLAmbrosoneCByrneCDavisWNeslineM 2010 Telomere length in blood cells and breast cancer risk: investigations in two case-control studies. Breast Cancer Res Treat 120 769 775

33. EpelESBlackburnEHLinJDhabharFSAdlerNE 2004 Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 101 17312 17315

34. ValdesAMAndrewTGardnerJPKimuraMOelsnerE 2005 Obesity, cigarette smoking, and telomere length in women. Lancet 366 662 664

35. von ZglinickiT 2002 Oxidative stress shortens telomeres. Trends Biochem Sci 27 339 344

36. AvivAValdesAMSpectorTD 2006 Human telomere biology: pitfalls of moving from the laboratory to epidemiology. Int J Epidemiol 35 1424 1429

37. Van ZiffleJABaerlocherGMLansdorpPM 2003 Telomere length in subpopulations of human hematopoietic cells. Stem Cells 21 654 660

38. MilneRLOsorioACajalTRVegaALlortG 2008 The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Clin Cancer Res 14 2861 2869

39. DiezOOsorioADuranMMartinez-FerrandisJIde la HoyaM 2003 Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat 22 301 312

40. MilneRLRibasGGonzalez-NeiraAFagerholmRSalasA 2006 ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping. Cancer Res 66 9420 9427

41. EastonDFPooleyKADunningAMPharoahPDThompsonD 2007 Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447 1087 1093

42. CawthonRM 2002 Telomere measurement by quantitative PCR. Nucleic Acids Res 30 e47

43. CoddVManginoMvan der HarstPBraundPSKaiserM 2010 Common variants near TERC are associated with mean telomere length. Nat Genet 42 197 199